Skip to main content
Equibles

Chicago Partners Investment Group LLC

Position in XERS — Xeris Biopharma Holdings, Inc.

CIK 1563525 CHICAGO, IL
Back to XERS Full portfolio

Position in XERS

as of Jun 30, 2026 · filed Jul 30, 2026
Position Value
$90,486
+$12,227 QoQ
Shares Held
11,425
-15.3% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#176
of 239 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 19% Shared 0% None 81%

Common Shares in XERS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Chicago Partners Investment Group LLC holds $3,695,869 across 13 Drug Manufacturers - Specialty & Generic names. XERS ranks #8 (2.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 NBIX
Neurocrine Biosciences Inc
 8,472 $1,427,870
2 UTHR
UNITED THERAPEUTICS Corp
 1,179 $638,817
3 ELAN
Elanco Animal Health Inc
 15,434 $379,830
4 ZTS
Zoetis Inc.
 5,190 $372,953
5 VTRS
Viatris Inc
 15,036 $238,771
6 EOLS
Evolus, Inc.
 22,248 $154,401
7 BCRX
Biocryst Pharmaceuticals Inc
 14,488 $144,880
8 XERS
Xeris Biopharma Holdings, Inc.
This page 		11,425 $90,486

All Filings in XERS

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $90,486 11,425
2026-03-31 $78,259 13,493